
Lisata Therapeutics Investor Relations Material
Latest events

Q1 2025
Lisata Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lisata Therapeutics Inc
Access all reports
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cell-based therapies for the treatment of advanced-stage diseases. The company's research and development efforts are primarily centered on addressing unmet medical needs in oncology, cardiovascular, and other serious conditions. Lisata leverages its proprietary technologies to create therapeutic solutions that promote tissue repair and regeneration. The company serves the healthcare sector with a focus on advancing treatments in areas where current options are limited. The company is headquartered in Basking Ridge, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Lisata Therapeutics Inc


Q2 2024
Lisata Therapeutics Inc


Q2 2024
Lisata Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
LSTA
Country
🇺🇸 United States